FR23C1026I1 - Fabrication de formulations d'arachides pour désensibilisation orale - Google Patents

Fabrication de formulations d'arachides pour désensibilisation orale

Info

Publication number
FR23C1026I1
FR23C1026I1 FR23C1026C FR23C1026C FR23C1026I1 FR 23C1026 I1 FR23C1026 I1 FR 23C1026I1 FR 23C1026 C FR23C1026 C FR 23C1026C FR 23C1026 C FR23C1026 C FR 23C1026C FR 23C1026 I1 FR23C1026 I1 FR 23C1026I1
Authority
FR
France
Prior art keywords
oral desensitization
formulations
manufacturing peanut
manufacturing
peanut formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR23C1026C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51528061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR23C1026(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of FR23C1026I1 publication Critical patent/FR23C1026I1/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR23C1026C 2013-03-14 2023-07-07 Fabrication de formulations d'arachides pour désensibilisation orale Active FR23C1026I1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361784964P 2013-03-14 2013-03-14
EP14776121.7A EP2968529B1 (fr) 2013-03-14 2014-03-12 Fabrication de formulations de cacahouète pour la désensibilisation orale
PCT/US2014/024401 WO2014159607A1 (fr) 2013-03-14 2014-03-12 Fabrication de formulations de cacahouète pour la désensibilisation orale

Publications (1)

Publication Number Publication Date
FR23C1026I1 true FR23C1026I1 (fr) 2023-10-06

Family

ID=51528061

Family Applications (1)

Application Number Title Priority Date Filing Date
FR23C1026C Active FR23C1026I1 (fr) 2013-03-14 2023-07-07 Fabrication de formulations d'arachides pour désensibilisation orale

Country Status (18)

Country Link
US (5) US9198869B2 (fr)
EP (3) EP2968529B1 (fr)
JP (3) JP6752140B2 (fr)
CN (2) CN105101994B (fr)
AU (5) AU2014240404B2 (fr)
BR (1) BR112015021756B1 (fr)
CA (1) CA2903229A1 (fr)
DK (2) DK2968529T3 (fr)
ES (2) ES2826224T3 (fr)
FI (2) FI3482771T3 (fr)
FR (1) FR23C1026I1 (fr)
HK (1) HK1217660A1 (fr)
HU (1) HUE051831T2 (fr)
MX (1) MX2015010315A (fr)
PL (1) PL2968529T3 (fr)
PT (1) PT2968529T (fr)
SI (1) SI2968529T1 (fr)
WO (1) WO2014159607A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
ES2826224T3 (es) * 2013-03-14 2021-05-17 Aimmune Therapeutics Inc Fabricación de formulaciones de maní para desensibilización oral
CN106535931A (zh) 2014-08-25 2017-03-22 艾慕恩治疗公司 卵蛋白制剂及其制备方法
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
LT3258962T (lt) 2015-02-20 2023-02-27 The Board Of Trustees Of The Leland Stanford Junior University Mišrios alergenų kompozicijos ir jų panaudojimo būdai
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
TW201709926A (zh) * 2015-04-23 2017-03-16 賽諾菲公司 用於舌下投藥之吡喃葡萄糖基脂ａ及過敏原調配物
US10856567B2 (en) 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
AU2016431600A1 (en) * 2016-12-05 2019-04-04 Reacta Biotech Limited Oral food challenge meal formulations
CA3050093A1 (fr) * 2017-01-13 2018-07-19 Aimmune Therapeutics, Inc. Procedes de fabrication de farines de noix et formulations pour immunotherapie orale
BR102017026619A2 (pt) 2017-02-15 2018-10-30 Euroimmun Medizinische Labordiagnostika Ag ensaio melhorado para a diagnose de alergia a amendoim
EP3654778A1 (fr) 2017-07-18 2020-05-27 Before Brands, Inc. Procédés de fabrication de compositions d'allergènes mixtes
WO2019089978A1 (fr) 2017-11-02 2019-05-09 Aimmune Therapeutics, Inc. Procédés d'immunothérapie orale
GB201718342D0 (en) * 2017-11-06 2017-12-20 Cambridge Allergy Ltd Allergenic protein formulations for immunotherapy
AU2019310602A1 (en) 2018-07-27 2021-02-04 Societe Des Produits Nestle S.A. Oral immunotherapy unit dose dispensing systems and methods
EP3897181A4 (fr) * 2018-12-17 2022-08-24 Société des Produits Nestlé S.A. Formulations pour immunothérapie orale par l'?uf, procédés de fabrication et traitements pour l'allergie à l'?uf
AU2019401214A1 (en) * 2018-12-20 2021-06-24 Société des Produits Nestlé S.A. Peanut oral immunotherapy dosing schedule for missed doses
WO2020154476A1 (fr) 2019-01-23 2020-07-30 Before Brands, Inc. Procédés de fabrication de compositions d'allergènes mixtes
EP3965815A4 (fr) 2019-05-10 2023-05-31 Société des Produits Nestlé S.A. Procédés d'amélioration de la qualité de vie d'un patient souffrant d'allergie à l'arachide
AU2020324553A1 (en) * 2019-08-08 2022-03-24 Evonik Operations Gmbh Method of preparing a solid dosage form and a lubricant
KR20220119076A (ko) * 2019-12-23 2022-08-26 프로타 테라퓨틱스 피티와이 엘티디 약학적 조성물
US20220220211A1 (en) 2021-01-08 2022-07-14 Regeneron Pharmaceuticals, Inc. Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist
TW202346316A (zh) 2022-04-11 2023-12-01 丹麥商Ａｌｋ 阿貝羅公司 花生過敏原組成物

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3809767A (en) * 1969-05-12 1974-05-07 Griffith Laboratories Methods of making vegetable protein concentrates
WO1992015285A1 (fr) 1991-03-01 1992-09-17 Warner-Lambert Company Compositions a liberation regulee a base d'amidon
US20120164306A1 (en) * 1993-08-03 2012-06-28 Girsh Leonard S Process for preparing hypoallergenic and reduced fat foods
JP3445593B2 (ja) * 1994-09-10 2003-09-08 株式会社林原生物化学研究所 ペプチドとその用途
US20020018778A1 (en) 1999-12-06 2002-02-14 Caplan Michael J. Passive desensitization
AU1951001A (en) 2000-04-06 2001-09-17 Panacea Pharm Llc Microbial delivery system
WO2004075875A1 (fr) 2003-02-28 2004-09-10 Alk-Abello A/S Forme de dosage presentant une matrice en saccharide
EP1734975B1 (fr) 2004-03-19 2015-06-10 Herbs Spring, LLC Therapie a base de plantes medicinales pour le traitement de l'allergie alimentaire
BRPI0520821A2 (pt) * 2005-12-28 2009-06-30 Teva Pharma formulações farmacêuticas de fenofibrato com biodisponibilidade melhorada
FR2924349B1 (fr) * 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
JP2012509329A (ja) 2008-11-19 2012-04-19 アバントール パフォーマンス マテリアルズ， インコーポレイテッド 直接圧縮可能で高機能性な顆粒状の微結晶性セルロースベース賦形剤、それらの製造プロセスおよび使用
CN102159201A (zh) 2008-12-19 2011-08-17 莫茨药物股份两合公司 用于治疗肥大细胞介导的疾病的1-氨基-烷基环己烷衍生物
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
EP2364690A1 (fr) * 2010-02-12 2011-09-14 Centro De Ingenieria Genetica Y Biotecnologia Granulé pharmaceutique pouvant être administré par voie orale du facteur de croissance épidermique
JP5800527B2 (ja) * 2010-03-30 2015-10-28 日東電工株式会社 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
AR081776A1 (es) * 2010-06-30 2012-10-17 Novartis Ag Composiciones farmaceuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona, proceso para la produccion de la composicion
CN101912364B (zh) * 2010-08-09 2015-07-15 刘会梅 银杏内酯b脂质体组合药物
GB201104537D0 (en) 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
CA2846858C (fr) * 2011-08-31 2022-03-08 Perosphere, Inc. Procedes pour la desensibilisation efficace et rapide de patients allergiques
WO2013087119A1 (fr) * 2011-12-16 2013-06-20 Hal Allergy Holding B.V. Formulations pharmaceutiques et leur utilisation pour le traitement d'allergie aux cacahuètes
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
ES2826224T3 (es) 2013-03-14 2021-05-17 Aimmune Therapeutics Inc Fabricación de formulaciones de maní para desensibilización oral
CN106535931A (zh) 2014-08-25 2017-03-22 艾慕恩治疗公司 卵蛋白制剂及其制备方法
CA3050093A1 (fr) 2017-01-13 2018-07-19 Aimmune Therapeutics, Inc. Procedes de fabrication de farines de noix et formulations pour immunotherapie orale
WO2019089978A1 (fr) 2017-11-02 2019-05-09 Aimmune Therapeutics, Inc. Procédés d'immunothérapie orale

Also Published As

Publication number Publication date
US11141352B2 (en) 2021-10-12
ES2940686T3 (es) 2023-05-10
PT2968529T (pt) 2020-11-10
US9198869B2 (en) 2015-12-01
BR112015021756B1 (pt) 2023-01-10
AU2022201858B2 (en) 2024-04-04
EP3998080A1 (fr) 2022-05-18
AU2020202685B2 (en) 2022-01-20
PL2968529T3 (pl) 2021-04-19
EP2968529A4 (fr) 2016-10-05
JP6752140B2 (ja) 2020-09-09
JP2021073321A (ja) 2021-05-13
WO2014159607A1 (fr) 2014-10-02
US20230120350A1 (en) 2023-04-20
CN109125283A (zh) 2019-01-04
FIC20230022I1 (fi) 2023-07-04
US20180042816A1 (en) 2018-02-15
US10449118B2 (en) 2019-10-22
AU2014240404B2 (en) 2016-07-21
AU2020202685A1 (en) 2020-05-14
CN105101994B (zh) 2018-10-12
DK2968529T3 (da) 2020-10-12
JP6891205B2 (ja) 2021-06-18
JP2016512537A (ja) 2016-04-28
AU2016231523A1 (en) 2016-10-06
AU2014240404A1 (en) 2015-09-17
EP3482771A1 (fr) 2019-05-15
AU2022201858A1 (en) 2022-04-07
US20160030289A1 (en) 2016-02-04
SI2968529T1 (sl) 2021-03-31
AU2018222980A1 (en) 2018-09-20
JP2019108357A (ja) 2019-07-04
BR112015021756A8 (pt) 2019-11-19
HUE051831T2 (hu) 2021-03-29
EP2968529B1 (fr) 2020-08-05
FI3482771T3 (fi) 2023-04-03
CN105101994A (zh) 2015-11-25
JP7454519B2 (ja) 2024-03-22
DK3482771T3 (da) 2023-03-20
HK1217660A1 (zh) 2017-01-20
AU2016231523B2 (en) 2018-05-31
MX2015010315A (es) 2016-04-13
ES2826224T3 (es) 2021-05-17
EP3482771B1 (fr) 2023-01-18
US20140271836A1 (en) 2014-09-18
US20200129378A1 (en) 2020-04-30
CA2903229A1 (fr) 2014-10-02
BR112015021756A2 (pt) 2017-07-18
EP2968529A1 (fr) 2016-01-20

Similar Documents

Publication Publication Date Title
FR23C1026I1 (fr) Fabrication de formulations d'arachides pour désensibilisation orale
CL2016000680A1 (es) Formulaciones de anticuerpos anti-pdl1.
BR112015020889A2 (pt) microcápsulas compreendendo agentes de proteção solar
FR3000784B1 (fr) Dispositif d'eclairage medical
DK3244878T3 (da) Faste orale sammensætningsformer
BR112016012154A2 (pt) instrumento de cuidado oral
FR3022462B1 (fr) Composition orale d'anticorps anti-tnfalpha
FR3007103B1 (fr) Dispositif d'eclairage
DK3041579T3 (da) Orale antiparasitære sammensætninger
BR112016011582A2 (pt) sistema oxidante para composições de higiene oral
DK3071191T3 (da) Faste orale sammensætninger med langsom frigivelse
FR3010388B1 (fr) Machine d'impression-emballage
BR112016002561A2 (pt) implemento de cuidado oral
FR3006617B1 (fr) Dispositif d'usinage vibratoire
FR3003940B1 (fr) Mire d'etalonnage pour camera
FR3014422B1 (fr) Ecarteur d'elingues
BR302013001547S1 (pt) "configuração aplicada em farol"
ITUB20153699A1 (it) Integratore orale
ES1094985Y (es) Mini-moto infantil
UA27823S (uk) Упаковка «вушка»
ES1092430Y (es) "Anafe paellero"
TH1601002939A (th) ระบบการออกซิไดซ์สำหรับองค์ประกอบดูแลช่องปาก
ITRA20130010U1 (it) "dispositivo per incidere la buccia delle castagne"
TH148213B (th) "อุปกรณ์เปลี่ยนน้ำมันด้วยตัวเอง"
FR3008769B1 (fr) Dispositif d'eclairage